Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q3 2025 value amounting to $929000.0.

  • Barinthus Biotherapeutics' Other Non-Current Assets rose 32.4% to $929000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $929000.0, marking a year-over-year increase of 32.4%. This contributed to the annual value of $881000.0 for FY2024, which is 11.34% down from last year.
  • According to the latest figures from Q3 2025, Barinthus Biotherapeutics' Other Non-Current Assets is $929000.0, which was up 32.4% from $944000.0 recorded in Q2 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' Other Non-Current Assets peaked at $1.1 million during Q3 2023, and registered a low of $719000.0 during Q3 2021.
  • In the last 5 years, Barinthus Biotherapeutics' Other Non-Current Assets had a median value of $902000.0 in 2022 and averaged $903529.4.
  • In the last 5 years, Barinthus Biotherapeutics' Other Non-Current Assets skyrocketed by 3045.69% in 2023 and then plummeted by 1391.05% in 2024.
  • Over the past 5 years, Barinthus Biotherapeutics' Other Non-Current Assets (Quarter) stood at $804000.0 in 2021, then grew by 21.39% to $976000.0 in 2022, then fell by 9.63% to $882000.0 in 2023, then decreased by 0.11% to $881000.0 in 2024, then grew by 5.45% to $929000.0 in 2025.
  • Its last three reported values are $929000.0 in Q3 2025, $944000.0 for Q2 2025, and $902000.0 during Q1 2025.